Conventional chemotherapy for acute myeloid leukemia: a Brazilian experience
São Paulo med. j
; 118(6): 173-8, Nov. 2000. graf, tab
Article
em En
| LILACS
| ID: lil-277625
Biblioteca responsável:
BR1.1
ABSTRACT
CONTEXT Young patients affected by acute myeloid leukemia (AML) achieve complete remission (CR) using conventional chemotherapy in about 55-85 percent. However, 30 percent of patients fail to achieve CR and the remission duration is often only about 12 months. More intensive treatment after CR seems to be necessary in order to maintain CR and obtain a definitive cure. In Brazil, few reports have been published on this important subject. OBJECTIVE:
The aim of this study was to describe a Brazilian experience in the treatment of "de novo" acute myeloid leukemia (AML) in younger adult patients (age < 60 years).DESIGN:
Retrospective analysis.SETTING:
University Hospital, Hematology and Hemotherapy Center, State University of Campinas, Brazil...
Texto completo:
1
Base de dados:
LILACS
Assunto principal:
Protocolos de Quimioterapia Combinada Antineoplásica
/
Leucemia Mieloide
Idioma:
En
Ano de publicação:
2000
Tipo de documento:
Article